[Therapy of rheumatoid arthritis: what influences the risk of infections and malignant neoplasms?].
ACURA-Rheumazentrum Baden-Baden.
C
C
Fiehn
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology*; D015984:Causality; D015897:Comorbidity; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D017053:Infection Control / Q000706:statistics & numerical data; D007239:Infections / Q000453:epidemiology*; D009369:Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D012307:Risk Factors
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents